About Thia Ventures
Thia Ventures is a venture capital firm founded in 2021. It is primarily based out of New York City, United States. As of Feb 2025, Thia Ventures has invested in 22 companies. It primarily invests in Seed round in United States based startups. Its investments are spread across a wide range of sectors from Food and Agriculture Tech to Enterprise Applications and High Tech. Most recently it participated in the $***** Seed round of uFraction8 Overall, Thia Ventures portfolio has seen 1 unicorn and 1 acquisition, namely Goodera and Pivot Bio. A lot of funds co-invest with Thia Ventures, with names like Blue Horizon sharing a substantial percentage of its portfolio. Thia Ventures has team of 5 people including 2 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed, Series A & 1 more
Portfolio Acquisitions
Portfolio Unicorns
Portfolio Soonicorns
Thia Ventures' List of Top Investments
Thia Ventures has a portfolio of 22 companies, one of which is a Unicorn. Their most notable investments are in Pow.Bio and Zymoptiq.Their portfolio spans across United States, France, Belgium and 6 more locations. They have invested in Food and Agriculture Tech, Enterprise Applications, High Tech and 10 other sectors, across stages such as Seed, Series A and 1 more. Here is the list of top investments by Thia Ventures:1. Goodera
Provider of scalable corporate volunteering programs. It connects corporations with nonprofits globally, facilitating employee volunteer events. The company offers a platform to manage and execute these programs, including in-person, virtual, and hybrid options. Services encompass pre-event planning, logistics, on-site support, and post-event reporting, aiming to maximize community impact and employee engagement. It provides a curated catalog of volunteer opportunities aligned with various causes.
Key facts about Goodera
- Founded Year: 2014
- Location: San Mateo (United States)
- Annual Revenue: ₹50 - ₹100 Cr as on Mar 31, 2025
- Last Known Valuation: $*****
- Stage: Acquired
- Total Funding till date: $29M
- Employee Count: 170 as on Aug 31, 2025
- Investors: Nexus Venture Partners, Elevation Capital and 46 Others
- Latest Funding Round: Grant (prize money), 2023, $*****
- Highlight: Acquired
Digital social networking platform for healthcare professionals. The company offers CHLOE (Consumer Health Learning and Organizing Ecosystem) software that integrates clinical care with scientific research and provides access, research participation, and education - networking patient communities with healthcare providers and scientists to provide scientifically proven optimal care in alternative medicines.
Key facts about People Science
- Founded Year: 2020
- Location: Los Angeles (United States)
- Stage: Seed
- Total Funding till date: $8.5M
- Employee Count: 41 as on Sep 30, 2026
- Investors: Lifeforce Capital, Noetic Psychedelic Fund and 5 Others
- Latest Funding Round: Seed, Jan 26, 2023, $*****
3. Protealis
Provider of legume seeds and programs for farmers and food producers. The company specializes in plant protein legumes designed as a sustainable alternative. It offers soy seed varieties and yellow pea programs. The seeds are designed to boost yield and protein. The company focuses on sustainable development, health, and agriculture.
Key facts about Protealis
4. Pivot Bio
Developer of microbial nitrogen products designed for crop nutrition enhancement. These products deliver nitrogen directly to plant roots, optimizing nutrient uptake. The company’s technologies enhance crop production through timed nitrogen delivery. It offers programs rewarding farmers for improving nitrogen practices. The company provides solutions for corn, wheat, sorghum, and other small grains.
Key facts about Pivot Bio
- Founded Year: 2010
- Location: Berkeley (United States)
- Valuation: $*****
- Stage: Series D
- Total Funding till date: $618M
- Employee Count: 307 as on Sep 30, 2026
- Investors: Generation Investment Management, Temasek and 26 Others
- Latest Funding Round: Series D, Jul 19, 2021, $*****
- Highlight: Editors' Pick
5. GOURMEY
Provider of meat alternatives. It offers lab grown cultivated meat alternatives and meat products made directly from animal cells.
Key facts about GOURMEY
- Founded Year: 2019
- Location: Paris (France)
- Stage: Series A
- Total Funding till date: $57.6M
- Employee Count: 58 as on Sep 30, 2026
- Investors: Earlybird, Sylvain Zimmer and 20 Others
- Latest Funding Round: Series A, Oct 05, 2022, $*****
Thia Ventures' Year-on-Year Investment Trends
Thia Ventures has invested in 22 companies over the last 11 years, with an average of 2 new investments annually in the last 10 years. In 2025, it made 1 investment. Its most recent first time investment was in Switch Bioworks and most recent follow-on round was in uFraction8.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 0 | 0 | 0 |
2025 | 0 | 1 | 1 |
2024 | 2 | 1 | 3 |
2023 | 4 | 0 | 4 |
2022 | 11 | 0 | 11 |
2021 | 1 | 0 | 1 |
Thia Ventures' Investments by Stage
Thia Ventures has made 10 investments in Seed stage with an average round size of $8.28M, 8 investments in Series A stage with an average round size of $15.7M and 1 investment in Series B stage with an average round size of $50M.Stage of entry | No. of Investments |
|---|---|
Seed | 10 |
Series A | 8 |
Series B | 1 |
Note: We have considered here, only first round of investments
Thia Ventures' Investments by Sector
Thia Ventures has a diverse portfolio, with companies operating in the Food and Agriculture Tech, Sustainability Tech, Food and Agriculture, High Tech and Life Sciences. Notably, it has invested in 17 Tech companies, 12 Enterprise (B2B) companies, 7 Consumer (B2C) companies and at least 2 companies focusing on Software.Sector | No. of Investments |
|---|---|
Food and Agriculture Tech | 7 |
Sustainability Tech | 5 |
Food and Agriculture | 4 |
High Tech | 4 |
Life Sciences | 4 |
Others | 10 |
Note: We have considered here, only first round of investments
Thia Ventures' Investments by Geography
Thia Ventures has made most investments in United States (9), followed by France where it has made 3 investments.Country | No. of Investments |
|---|---|
United States | 9 |
France | 3 |
Belgium | 2 |
Denmark | 2 |
China | 1 |
Others | 3 |
Note: We have considered here, only first round of investments
Thia Ventures' recent investments
Thia Ventures has not made any investment in 2026 so far.Here are the most recent investments by Thia Ventures:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Feb 24, 2025 | United Kingdom | Seed | 3444 | [+3] | |
Aug 21, 2024 | United States | Seed | 6097 | [+6] | |
May 03, 2024 | Singapore | Series A | 1340 | [+6] | |
Jan 23, 2024 | Belgium | Series B | 8132 | [+11] | |
Oct 04, 2023 | United States | Series A | 3331 | [+9] |
Unicorns in Thia Ventures' Portfolio
Thia Ventures has 1 unicorn in its portfolio - Pivot Bio. The most recent unicorn in their portfolio is Pivot Bio which became a unicorn in 2021, 5 years before Thia Ventures first invested in it.Here is a list of unicorns in Thia Ventures' portfolio:
Tracxn Score | Company | Short Description | Founded year | Sector | Location | Company Stage | First Investment/ Acquisition Details |
|---|---|---|---|---|---|---|---|
58 | Developer of microbial nitrogen products designed for crop nutrition enhancement | 2010 | Berkeley | Series D | plkweuu |
Acquired companies in Thia Ventures' Portfolio
1 company from Thia Ventures' portfolio has been acquired. The most recent acquisition was Goodera in Dec 2023 by Uniqus for $*****.Here are Thia Ventures' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Dec 06, 2023 | Apr 02, 2015 | Seed | 2453 |
Team profile of Thia Ventures
Thia Ventures has a team of 5 members including 2 Partners located in Switzerland and Belgium. Thia Ventures' team does not sit on the board of any company as of now.Co-investors of Thia Ventures
Over the past 11 years, 203 investors have co-invested in Thia Ventures's portfolio companies. This includes funds and angels.
- Invested before Thia Ventures: EIC Fund, Europa and 62 others have invested in rounds before Thia Ventures. There are 3 companies where EIC Fund has invested before Thia Ventures and 3 companies where Europa has invested before Thia Ventures.
- Top Co-investors of Thia Ventures: 98 investors entered a company along with Thia Ventures. These include investors like Blue Horizon (4 companies).
- Invested after Thia Ventures: A total of 41 investors have invested in Thia Ventures's portfolio after their investments. Top Investors include Teneo (1 company), Ursula Burns (1 company) and Declan Kelly (1 company).
Recent News related to Thia Ventures
•
uFraction8 eyes growth with £3.4 million backingBdaily•Feb 25, 2025•uFraction8, Foresight Group, Old College Capital, Scottish Enterprise and 2 others
•
uFraction8 Raises £3.4M in FundingFinSMEs•Feb 24, 2025•uFraction8, Foresight Group, Old College Capital, Scottish Enterprise and 3 others
•
Biotech Firm uFraction8 Raises Funds for ExpansionDaily Business•Feb 24, 2025•uFraction8, Foresight Group, Old College Capital, Scottish Enterprise and 4 others
•
UFraction8, co-created by a Polish woman, receives PLN 17 million in fundingMy Company Polska•Feb 24, 2025•uFraction8, Foresight Group, Old College Capital, Scottish Enterprise and 3 others
•
Switch Bioworks Bags $17M to Develop Sustainable FertilizersiGrow News•Sep 06, 2024•Switch Bioworks, Grantham Foundation, Astanor, Acre Venture Partners and 4 others
•
Copenhagen-based EvodiaBio secures €7 million aiming to revolutionise the market for sustainable aromaZephyrnet•Jun 07, 2024•EvodiaBio, The March Group, Cellugy, NIL Technology and 6 others
•
Singapore’s Allozymes raises $15M in Series A funding led by Seventure Partners, Xora InnovationTechNode•May 15, 2024•Allozymes, Seventure Partners, Xora Innovation, NUS Technology and 3 others
•
Singapore-based startup Allozymes raises $15 M paving way for new partnerships in pharma and life science industryBioSpectrum Asia•May 14, 2024•Allozymes, Seventure Partners, Xora Innovation, NUS Technology and 3 others
•
Allozymes Raises $15 Million in Series A Funding, Poised to Revolutionize Industries with Enzymatic SolutionsMacau Business•May 14, 2024•Allozymes, Seventure Partners, Xora Innovation, NUS Technology and 4 others
•
